Respirerx Pharmaceuticals, Inc.
Cover
Document and Entity Information
Financial Statements
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Operations (Parenthetical)
Condensed Consolidated Statements of Stockholders' Deficiency
Condensed Consolidated Statements of Stockholders' Deficiency (Parenthetical)
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows (Parenthetical)
Notes to Financial Statements
Organization and Basis of Presentation
Business
Summary of Significant Accounting Policies
Notes Payable
Settlement and Payment Agreements
Stockholders' Deficiency
Income Taxes
Related Party Transactions
Commitments and Contingencies
Subsequent Events
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Summary of Significant Accounting Policies (Tables)
Notes Payable (Tables)
Stockholders' Deficiency (Tables)
Income Taxes (Tables)
Commitments and Contingencies (Tables)
Subsequent Events (Tables)
Notes Details
Business (Details Narrative)
Business (Details Narrative) (10-K)
Summary of Significant Accounting Policies (Details Narrative) (10-K)
Summary of Significant Accounting Policies - Summary of Fair Value of Option Estimated Using Black-Scholes Pricing Model with Valuation Assumptions (Details) (10-K)
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) (10-K)
Notes Payable (Details Narrative)
Notes Payable (Details Narrative) (10-K)
Notes Payable - Summary of Note Payable to Related Party (Details)
Notes Payable - Summary of Note Payable to Related Party (Details) (10-K)
Notes Payable - Schedule of Convertible Notes Payable (Details)
Notes Payable - Schedule of Convertible Notes Payable (Details) (10-K)
Notes Payable - Schedule of Convertible Notes Payable (Details) (10-K) (Parenthetical)
Settlement and Payment Agreements (Details Narrative)
Settlement and Payment Agreements (Details Narrative) (10-K)
Stockholders' Deficiency (Details Narrative)
Stockholders' Deficiency (Details Narrative) (10-K)
Stockholders' Deficiency - Schedule of Warrants Activity (Details)
Stockholders' Deficiency - Schedule of Warrants Activity (Details) (10-K)
Stockholders' Deficiency - Schedule of Exercise Prices of Common Stock Warrants Outstanding and Exercisable (Details)
Stockholders' Deficiency - Schedule of Exercise Prices of Common Stock Warrants Outstanding and Exercisable (Details) (10-K)
Stockholders' Deficiency - Summary of Stock Option Activity (Details)
Stockholders' Deficiency - Summary of Stock Option Activity (Details) (10-K)
Stockholders' Deficiency - Schedule of Exercise Prices of Common Stock Options Outstanding and Exercisable (Details)
Stockholders' Deficiency - Schedule of Exercise Prices of Common Stock Options Outstanding and Exercisable (Details) (10-K)
Income Taxes (Details Narrative) (10-K)
Income Taxes - Schedule of Deferred Tax Assets (Details) (10-K)
Income Taxes - Reconciliation of Income Tax Rate Federal Statutory Rate and Effective Tax Rate (Details) (10-K)
Commitments and Contingencies (Details Narrative)
Commitments and Contingencies (Details Narrative) (10-K)
Commitments and Contingencies - Summary of Principal Cash Obligations and Commitments (Details)
Commitments and Contingencies - Summary of Principal Cash Obligations and Commitments (Details) (10-K)
Subsequent Events (Details Narrative)
Subsequent Events (Details Narrative) (10-K)
Subsequent Events - Summary of Conversions of Convertible Notes (Details)
Subsequent Events - Summary of Exercises of Warrants (Details)
All Reports
Filing Date:
10-14-2020
Form Type:
Form S-1
Description:
General form for registration of securities under the Securities Act of 1933